Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-17-000754
Filing Date
2017-02-02
Accepted
2017-02-02 14:23:15
Documents
1
Period of Report
2017-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148606338202189.html 4  
1 FORM 4 wf-form4_148606338202189.xml 4 3872
  Complete submission text file 0001628280-17-000754.txt   5242
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCYNEXIS, INC. 3501 C TRICENTER BOULEVARD DURHAM NC 27713
Business Address
Angulo Gonzalez David (Reporting) CIK: 0001644071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 17567844